VR goggles vs. pills: new trial tests tech for teen depression
NCT ID NCT07452341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a virtual reality headset for 30 minutes each week can reduce depression in teenage girls aged 13-18. Half the participants will use VR, while the other half take standard antidepressant pills. Researchers will measure changes in depression scores and quality of life after 8 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- virtual reality headset
- What this could lead to
- If it works, this could offer a non-drug option to help ease depression symptoms in adolescent girls.
- What could go wrong
- This is a small, early-stage study with only 48 participants, so results may not apply widely. VR may not work as well as standard medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers